Profil bibliographique

Mariana Lima

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

3Publications signalées
0Citations signalées
2Affiliations récentes

Les institutions déclarées

Administração Regional de Saúde de Lisboa e Vale do TejoHospital de Santa Maria

Les domaines associés

Hemophilia Treatment and ResearchAutoimmune and Inflammatory Disorders ResearchAcute Lymphoblastic Leukemia researchSimulation-Based Education in HealthcareArtificial Intelligence in Healthcare and Education

Les publications récentes

Accès ouvert 2026 article OpenAlex

The use of artificial intelligence technologies in the development of clinical communication skills among undergraduate health professions students: a scoping review protocol

Mariana Lima, Lígia Lima, Celeste Bastos, Teresa Vieira Martins

Introdução: A comunicação clínica é uma competência central na formação em saúde, associada à qualidade dos cuidados e à segurança do doente. Em paralelo, a rápida incorporação de tecnologias de inteligência artificial (IA) em contextos educativos tem produzido resultados inconsistentes quanto a …

pt (code pays fourni par la source)

0 citations RevSALUS - Revista Científica da Rede Académica das Ciências da Saúde da Lusofonia
Accès ouvert 2026 article OpenAlex

Emapalumab’s role in a severe and treatment-resistant paediatric macrophage activation syndrome

Roberto Pereira da Costa, Mariana Lima, Sofia Guedes, Marisa Vieira et autres

Introduction Macrophage activation syndrome (MAS) is a life-threatening hyperinflammatory condition. Emapalumab, an IFNγ-directed antibody, is approved for use in the USA but not in Europe. Case A 15-year-old girl presented with fever, odynophagia and a transient rash. After 9 days of hospitalization …

pt (code pays fourni par la source)

0 citations ARP Rheumatology
Accès ouvert 2026 article OpenAlex

Emapalumab’s role in a severe and treatment-resistant paediatric macrophage activation syndrome

Roberto Pereira da Costa, Mariana Lima, S. M. Guedes, Marisa Vieira et autres

Introduction Macrophage activation syndrome (MAS) is a life-threatening hyperinflammatory condition. Emapalumab, an IFNγ-directed antibody, is approved for use in the USA but not in Europe. Case A 15-year-old girl presented with fever, odynophagia and a transient rash. After 9 days of hospitalization …

pt (code pays fourni par la source)

0 citations DOAJ (DOAJ: Directory of Open Access Journals)
Profil ORCIDNotice OpenAlex

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.